Showing: 19 - 24 of 24 Articles

The Journal of the American Medical Association Finally Questions Whether the FDA Should be Approving Useless No-Evidence Cholesterol-Lowering Drugs

After the Coronary Primary Prevention Trial, fittingly published in 1984, showed that cholestyramine, a drug that lowers cholesterol by causing its conversion to bile acids, could reduce the risk of heart attacks, cholesterol was widely villainized as a killer. From then on, the decades-old campaign of the American Heart Association against eggs and butter was …

Do Blockages In Coronary Arteries Really Cause Heart Attacks?

Last weekend I was invited to speak at the Freedom Law School’s 2009 Health and Freedom Conference, which was an interesting mix of nutrition and politics, the latter portion largely devoted to opposition to the income tax, opposition to the Federal Reserve, and alternative theories about what happened on September 11, 2001. I don’t agree …

The Total-to-HDL Cholesterol Ratio — What Does It Mean?

Someone recently forwarded to me two references that a high-level New Zealand professor had used to support recommendations against saturated fat and coconut oil. The references did not support the conclusion at all, but they did provide some interesting insight about the importance of the total-to-HDL cholesterol ratio and its dietary implications. Both of the …

JUPITER Trial Emphasizes the Role of Oxidative Degeneration in Atherosclerosis

by Chris Masterjohn The most recent widely publicized trial using the cholesterol-lowering statin drugs, the JUPITER trial, has been enthusiastically hailed as a justification for the expansion of these expensive drugs from people with high cholesterol levels to those who have low-grade inflammation but normal cholesterol. The study hardly justifies this enthusiasm. It does, however, …